No Data
No Data
Edesa Biotech Analyst Ratings
H.C. Wainwright Maintains Edesa Biotech(EDSA.US) With Buy Rating, Maintains Target Price $21
Express News | Edesa Biotech Shares Are Trading Higher After BARDA Selected the Company's Drug for a U.S. Funded Platform Trial in General Acute Respiratory Distress Syndrome
Express News | Edesa Biotech Inc: Barda Selects Co's Drug for U.S. Funded Platform Trial in General Ards
Edesa Biotech Shareholders Approve Board and Compensation Plans
Edesa Biotech | 10-Q: Quarterly report
No Data